Cell Signaling Technology

LysRS Antibody

#5341 · $317

100
Citing papers
14.9k
Combined citations
Supplier page Find this product

Research areas

Cell death mechanisms and regulation12MicroRNA in disease regulation11Cancer-related Molecular Pathways9interferon and immune responses9Cancer Immunotherapy and Biomarkers8Circular RNAs in diseases7Autophagy in Disease and Therapy6Cancer Cells and Metastasis6

Papers citing this product

1
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Cell Reports·2017·1.9k cit.·DOI
2
Chromosomal instability drives metastasis through a cytosolic DNA response
Nature·2018·1.5k cit.·DOI
3
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
JAMA Oncology·2015·834 cit.·DOI
4
Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
Blood·2007·575 cit.·DOI
5
TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells
Cell Reports·2020·450 cit.·DOI
6
MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1
Gastroenterology·2008·422 cit.·DOI
7
Plant and Animal Pathogen Recognition Receptors Signal through Non-RD Kinases
PLoS Pathogens·2006·277 cit.·DOI
8
Histone modifications and their role in epigenetics of atopy and allergic diseases
Allergy Asthma and Clinical Immunology·2018·257 cit.·DOI
9
Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome
Nature Communications·2021·231 cit.·DOI
10
Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
Molecular Cancer Research·2011·223 cit.·DOI

Similar products

ProductVendorPricePapers
LysRS (D16D1) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$16195
LysRS Antibody — Evidence — PubIndex